Imprimis to offer low-cost alternative to Restasis for dry eye disease
Imprimis Pharmaceuticals is set to provide its cyclosporine-based formulations as customisable and potential low-cost alternatives to Restasis indicated for dry eye disease. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - October 22, 2017 Category: Pharmaceuticals Source Type: news
AbbVie's hepatitis C drug recommended for use within UK NHS Wales
The All Wales Medicines Strategy Group (AWMSG) has recommended AbbVie ’s Maviret for use within NHS Wales, UK, to treat adults suffering from chronic hepatitis C virus (HCV) infection. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - October 22, 2017 Category: Pharmaceuticals Source Type: news
Facility Shutdown Management: Best Industry Practices
" Planned " shutdown maintenance is vital for any production facility. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - October 22, 2017 Category: Pharmaceuticals Source Type: news
Plastiape to Attend CPhI Trade Show in Frankfurt
Plastiape will participate at CPhI in Frankfurt as a member of the RPC Group after the acquisition by RPC, which took place at the beginning of 2017. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - October 20, 2017 Category: Pharmaceuticals Source Type: news
Upcoming Events: ROVI
ROVI has announced it will be attending a number of events from October 2017 to April, 2018. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - October 20, 2017 Category: Pharmaceuticals Source Type: news
Gerresheimer Innovation at CPhI
Gerresheimer has announced it will be showcasing its innovative products at CPhI Worldwide, Frankfurt. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - October 20, 2017 Category: Pharmaceuticals Source Type: news
B & W Tek to Attend CPhI, Frankfurt
B&W Tek has announced that it will be showcasing its products at CPhI Worldwide, Frankfurt. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - October 20, 2017 Category: Pharmaceuticals Source Type: news
Pall Corporation Introduces Stax mAx
The Stax mAx clarification platform is a single-use, robust depth filtration solution for the economic clarification of monoclonal antibody cell cultures without the need for centrifugation or process additives. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - October 20, 2017 Category: Pharmaceuticals Source Type: news
Cadence Acoustic Separator
The Cadence Acoustic Separator (CAS) enables the continuous removal of Chinese Hamster Ovary (CHO) cells and cell debris using a Cadance single-use acoustic chamber to achieve clarification of harvested cell culture fluid (HCCF) ready for downstream … (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - October 20, 2017 Category: Pharmaceuticals Source Type: news
Pharma Technology Focus – Issue 64
In this issue: Using drugs after their expiration dates have passed, treating lactose intolerance, a closer look at CARB-X ’s work on antibacterial R&D, helping nanomedicines reach their target, radioactive isotopes battling cancer, and more. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - October 20, 2017 Category: Pharmaceuticals Source Type: news
Move Beyond Mediocre CAPAS
Have you ever wondered why some of your CAPAs fail to achieve the desired improvement? (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - October 20, 2017 Category: Pharmaceuticals Source Type: news
M & As this week: WuXi AppTec, Cachet Pharmaceutical, Shenzhen Neptunus Bioengineering
Chinese pharmaceutical company WuXi AppTec plans to acquire US-based contract research organisation (CRO) ResearchPoint Global (RPG). (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - October 19, 2017 Category: Pharmaceuticals Source Type: news
Deals this week: Harbin Gloria Pharmaceuticals, F. Hoffmann-La Roche, Intrexon
Chinese pharmaceutical company Harbin Gloria Pharmaceuticals intends to issue medium-term notes due 2019 in a public offering to raise CNY1.6bn ($243.13m). (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - October 19, 2017 Category: Pharmaceuticals Source Type: news
Teva submits BLA for fremanezumab to FDA for migraine prevention
Teva Pharmaceutical Industries has submitted a biologics licence application (BLA) for fremanezumab to the US Food and Drug Administration (FDA) for migraine prevention. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - October 19, 2017 Category: Pharmaceuticals Source Type: news
Shanghai Pharma provides update on reports about Cardinal Health deal
Shanghai Pharmaceuticals has issued a clarification on media reports about its acquisition of Cardinal Health ’s pharmaceutical distribution business in China. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - October 19, 2017 Category: Pharmaceuticals Source Type: news
